A drug molecule “invented” by artificial intelligence (AI) will be used in human trials in a world first for machine learning in medicine.
It was created by British start-up Exscientia and Japanese pharmaceutical firm Sumitomo Dainippon Pharma.
The drug will be used to treat patients who have obsessive-compulsive disorder (OCD).
Typically, drug development takes about five years to get to trial, but the AI drug took just 12 months.
Exscienta chief executive Prof Andrew Hopkins described it as a “key milestone in drug discovery”.
He told the BBC: “We have seen AI for diagnosing patients and for analysing patient data and scans, but this is a direct use of AI in the creation of a new medicine.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
AI designed drug
- Recursion Completes Supercomputer for AI Drug Discovery
Artificial intelligence (AI)-based drug developer Recursion said it has completed the fastest supercomputer to be wholly owned and operated by any pharmaceutical company worldwide, using technology ...
- Using generative AI, Insilico Medicine discovers potent, selective small-molecule cancer inhibitor targeting CDK8
Insilico Medicine (“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced that it has successfully discovered a potent, selective, and ...
- Kickstarting the use of AI for biotechs: part one
Of course, with the billions of dollars being invested in AI-led drug discovery programmes, one would think that this is a pivotal moment in patient treatment – like Isomorphic Labs, Recursion, ...
- Google DeepMind Unveils Next-Gen AI Drug Discovery Model
The third version of the "AlphaFold" AI model will help scientists target diseases and design new medications.
- DeepMind CEO Targets $100 Billion-Plus AI Drug Discovery Business With AlphaFold
First AI-designed drugs may be ready for testing in “next couple of years,” Google’s AI boss Demis Hassabis tells Bloomberg Television ...
Go deeper with Google Headlines on:
AI designed drug
[google_news title=”” keyword=”AI designed drug” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Machine learning in medicine
- Reducing bias in medical AI solutions
A newborn in a medical incubator – associative photo. Image credit: Hush Naidoo Jade Photography via Unsplash, free license ...
- Machine learning unveils hidden gender differences in brain structure
Artificial intelligence (AI) computer programs that process MRI results show differences in how the brains of men and women are organized at a cellular level, a new study shows.
- Study Highlights Limits of Machine Learning in Surgical Predictions
Prediction models generated by Machine Learning are being increasingly used in medicine to identify risk factors and possible outcomes, especially for total joint replacements of knees and hips – alth ...
- Machine learning sheds light on gene transcription
A team led by researchers at UT Southwestern Medical Center has developed deep learning models to identify a simple set of rules that govern the activity of promoters—regions of DNA that initiate the ...
- 15 Patient Advocacy Groups Join Patients Rising to Urge Congress to Recognize Value of Artificial Intelligence (AI) in Medical Imaging
Today, Patients Rising, alongside 14 other patient advocacy groups, submitted a letter to members of Congress urging them to encourage the Centers ...
Go deeper with Google Headlines on:
Machine learning in medicine
[google_news title=”” keyword=”machine learning in medicine” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]